Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Recordati Industria Chimica E Farmaceutica S.P.A. (RCDTF) had Revenue of $2.53B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$2.53B
Net Income	$450.70M
Cost of Goods Sold	$802.15M
Gross Profit	$1.73B
Operating Expenses	$1.84B
Operating Income	$691.31M
Non-Operating Income/Expense	$-99.20M
Pre-Tax Income	$592.11M
Normalized Pre-Tax Income	$592.11M
Income after Taxes	$450.70M
Income from Continuous Operations	$450.70M
Consolidated Net Income/Loss	$450.70M
Normalized Income after Taxes	$450.70M
EBIT	$691.31M
EBITDA	$872.04M
Weighted-Average Shares Outstanding (Basic)	206.32M
Weighted-Average Shares Outstanding (Diluted)	206.32M
Earnings per Share (EPS) (Basic)	$2.18
Earnings per Share (EPS) (Diluted)	$2.16
Balance Sheet Financials
Current Assets	$1.61B
Property, Plant, and Equipment	$223.67M
Long-Term Assets	$3.94B
Total Assets	$5.56B
Current Liabilities	$1.01B
Long-Term Debt	$2.35B
Long-Term Liabilities	$2.52B
Total Liabilities	$3.53B
Common Equity	$2.03B
Tangible Shareholders Equity	$-1.55B
Shareholders Equity	$2.03B
Common Shares Outstanding	206.30M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$616.71M
Cash Flow from Investing Activities	$-914.31M
Cash Flow from Financial Activities	$402.66M
Beginning Cash	$240.02M
End Cash	$348.89M
Increase/Decrease in Cash	$108.87M
Stock-Based Compensation	$17.88M
Common Stock Dividends Paid	$-274.55M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.61
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.54
Debt to Equity Ratio	1.32
Gross Margin	68.34%
Operating Margin	27.28%
EBIT Margin	27.28%
EBITDA Margin	34.42%
Pre-Tax Profit Margin	23.37%
Profit Margin	17.79%
Free Cash Flow	$579.06M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.46
Inventory Turnover	1.46
Receiveable Turnover	3.74
Days Sales in Receivables	97.54
Return on Equity	22.19%
Return on Tangible Equity	-29.06%
Return on Assets	8.11%
Return on Investments	10.28%
Book Value Per Share	$9.84
Free Cash Flow per Share	$2.81
Operating Cash Flow per Share	$2.99

Data from Zacks Investment Research, Inc.